X Congress with international participation «Development of pharmacoeconomics and pharmacoepidemiology in the Russian Federation», 4-5 April 2016, Nizhny Novgorod

Bashlakova E.E., Evdoshenko E.P., Polyakova K.I., Skoromets A.A., Solodun I.Y., Fisun A.G., Holownia M.A. 4891

Budget impact analysis of the inclusion of teriflunomid in the program «7 high cost diseases» on the budget of the federal and regional authorities of the Russian Federation in the field of health care for patients with multiple sclerosis

Reshetko O.V., Yakimova Y.N. 5130

Pharmacists actions in antibiotics sales

Miroshnichenko Y.V., Scherba M.P. 4348

Cost analysis of antidiabetic drugs in the health care delivery attached to the military medical organizations diabetic patients in outpatient settings

Ardenova N.N., Rizhenkova I.G., Chernaya E.V. 4240

Insulinotherapy of diabetes mellitus in patients with hypertension

Burbello A.T., Gaykovaja L.B., Zagorodnikova K.A., Kosticina M.A., Pokladova M.V., Fedorenko A.S. 4429

Possibilities of сliniсo-eсonomiс analysis in work of clinical pharmacologist

Ugrekhelidze D.T. 4123

Pharmacoeconomic study of the use of botulinum toxin type A in the treatment of spastic forms of cerebral palsy in Moscow region

Ardenova N.N., Reshetko O.V., Rykalina E.B., Sokolov A.V., Furman N.V. 4435

Pharmacotherapy of heart insufficiency in hospital

Krasilnikov D.M., Safiullin M.R., Shakirova D.H. 4208

Analysis of hospital costs of antibiotic therapy in patients with destructive pancreatitis

Strunina (Rybchenko) Y.V. 4393

Using pharmacoeconomic analysis of the Russian Federation

Pochuprina A.A. 4197

The relevance of cost of illness analysis of systemic lupus erythematosus from perspective health care system of Russian Federation

Ponomareva A.A. 4383

Aapplication of pharmacoeconomic methods for the selection of the optimal scheme of anti-microbial therapy of pyelonephritis in children

Nosova P.S., Reshetko O.V. 4268

Pharmacoepidemiologic analysis of antipsychotic adverse effects in schizophrenia in different hospitals

Makarova E.I. 4333

Features of pharmacoeconomic evaluation of the application of inhaled drugs with modern delivery devices in patients with bronchial asthma

Levitan A.I., Reshetko O.V. 4356

Adherence to drug therapy on rheumatoid arthritis

Baytman T.P., Ivlichev A.V., Levitan A.I., Reshetko O.V. 4109

Pharmacoepidemiologic analysis of peptic ulcer pharmacotherapy in Saratov gastroenterologic department

Balykina Y.E., Kolbin A.S., Kurylev A.A., Mosikyan A.., Proskurin M.A., Chzhao V.. 4299

Comparative clinical and economic analysis of the outcomes of type 2 diabetes mellitus (T2DM) treated with insulin glargin or insulin degludec in combination with oral antidiabetic agents (OAD)

Balykina Y.E., Kolbin A.S., Kurylev A.A., Mosikyan A.., Proskurin M.A., Chzhao V.. 4332

Comparative clinical and economic analysis of the outcomes of type 2 diabetes mellitus (T2DM) treated with insulin glargin or insulin degludec as part of basal-bolus therapy

Balykina Y.E., Kolbin A.S., Kurylev A.A., Mosikyan A.., Proskurin M.A., Chzhao V.. 4276

Comparative clinical and economic analysis of the outcomes of type 1 diabetes mellitus (T1DM) treated with insulin glargin or insulin degludec as part of basal-bolus therapy

Zhukova O.V. 4431

Fishburnes method, Monte Carlo simulation and the classical method of pharmacoeconomic analysis in the evaluation of antibiotic treatment of acute bronchitis with bronchospasm in children

Dolotovskaya P.V., Malinova L.I., Reshetko O.V., Furman N.V. 4259

Pharmacoepidemiology of P2Y12 receptors blockers in acute coronary syndrome with ST elevation in real clinical practice

Dolotovskaya P.V., Malinova L.I., Reshetko O.V., Furman N.V. 4322

Ratio “cost-effectiveness” for clopidogrel and tikagrelor in acute coronary syndrome with ST elevation in real clinical practice

Gorbatenko V.S., Maslakov A.S., Shatalova O.V. 4238

Retail sales monitoring of oral anticoagulants in Volgograd

Abdrashitova G.T. 4197

X Congress with international participation «Development of pharmacoeconomics and pharmacoepidemiology in the Russian Federation»
4-5 April 2016 year, Nizhny Novgorod